According to DelveInsight, the Allergic Rhinitis market in 7MM is expected to witness a major change in the study period 2019-2032

DelveInsight's "Allergic Rhinitis Market" report provides a thorough comprehension of the Allergic Rhinitis, historical and forecasted epidemiology, and the Allergic Rhinitis market trends in the 7MM [the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan]. The Allergic Rhinitis market report also proffers an analysis of the current Allergic Rhinitis treatment algorithm/practice, market drivers, market barriers, and unmet medical needs.
The Allergic Rhinitis market is expected to show positive growth, mainly attributed to the increased diagnosed prevalence and also, the launch of upcoming devices during the forecast period. Moreover, advances in disease mechanisms have yielded new diagnostic and treatment approaches, opening avenues to better treatment interventions.

Key Takeaways from Allergic Rhinitis Market Report
• Allergic Rhinitis market is expected to grow significantly owing to an increase in upcoming novel treatment options, increasing market size due to increasing prevalence, increasing global healthcare investment and funding, increasing pollutants in the environment, and the ongoing development of precision medicine.
• According to Centers for Disease Control and Prevention (CDC), symptoms of allergic rhinitis can occur during certain seasons or year-round, depending on the allergen, and affect as many as 60 million people per year in the United States.
• Allergic Rhinitis Market Companies included Novartis Pharmaceuticals, ALK-Abello, Torii Pharmaceutical, Stallergenes Greer, FAES Farma, Taiho Pharmaceuticals, Allergy Therapeutics, Regeneron Pharmaceuticals, AOBiome, Emergo Therapeutics, Inmunotek, and several others.
• Allergic Rhinitis Market Therapies included Zolea (Omalizumab), Odactra/Acarizax/Miticure (House dust mite allergy immunotherapy [HDM SLIT-tablet]), Grastek/Grazax (Grass pollen allergy vaccine tablet), Itulazax (SQ tree SLIT-tablet), and several others.

Download Sample Report- https://www.delveinsight.com/sample-request/allergic-rhinitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Allergic Rhinitis Overview
Allergic rhinitis is a condition that occurs when the body (the immune system) overreacts to something in the environment (triggers). It is caused by allergens, which are usually harmless substances but trigger an allergic reaction in some people. When the symptoms occur in late summer or early fall, some people call it hay fever.
Allergic Rhinitis Epidemiology Insights
As per the DelveInsight estimates, in 2021, the total diagnosed cases of allergic rhinitis were around 99 M in the 7MM. These cases are expected to grow with a significant CAGR in the study period 2019-2032.

Allergic Rhinitis Epidemiology Segmentation in the 7MM
• Total Allergic Rhinitis Prevalent Cases
• Total Allergic Rhinitis Diagnosed Cases
• Total Allergic Rhinitis Allergen-specific Cases
• Total Allergic Rhinitis Treated Cases
• Total Allergic Rhinitis Age Group-Specific Cases

Allergic Rhinitis Treatment Landscape
The first-line treatment of allergic rhinitis involves the avoidance of relevant allergens (e.g., house dust mites, molds, pets, pollens) and irritants (e.g., tobacco smoke). Patients allergic to house dust mites should be instructed to use allergen-impermeable covers for bedding and to keep the relative humidity in the home below 50% (to inhibit mite growth).

Allergic Rhinitis Emerging Therapies
• Xoliar (Omalizumab): Novartis Pharmaceuticals
• REGN1908-1909 and REGN5713-5714-5715: Regeneron Pharmaceuticals
• MM09 and MG01: Inmunotek

Allergic Rhinitis Market Insights
Allergen-specific immunotherapy is the treatment in which a patient's immune system is rendered tolerant to an allergen by giving increasing doses of the allergen in a controlled fashion. There are two main routes by which immunotherapy is administered; subcutaneously and sublingually- Subcutaneous immunotherapy involves allergen injections at regular time intervals in a hospital by trained medical staff. With treatment lasting several years, patient commitment to attending hospital appointments is essential.

Scope of the Allergic Rhinitis Market Report
• Coverage- 7MM
• Study Period- 2019-2032
• Forecast Period- 11 Years
• Allergic Rhinitis Market Companies included Novartis Pharmaceuticals, ALK-Abello, Torii Pharmaceutical, Stallergenes Greer, FAES Farma, Taiho Pharmaceuticals, Allergy Therapeutics, Regeneron Pharmaceuticals, AOBiome, Emergo Therapeutics, Inmunotek, and several others.
• Allergic Rhinitis Market Therapies included Zolea (Omalizumab), Odactra/Acarizax/Miticure (House dust mite allergy immunotherapy [HDM SLIT-tablet]), Grastek/Grazax (Grass pollen allergy vaccine tablet), Itulazax (SQ tree SLIT-tablet), and several others.
• Market Drivers and Barriers

Request Sample Report- https://www.delveinsight.com/sample-request/allergic-rhinitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Key Insights
2. Executive Summary of Allergic Rhinitis
3. Competitive Intelligence Analysis for Allergic Rhinitis
4. Allergic Rhinitis: Market Overview at a Glance
5. Allergic Rhinitis: Disease Background and Overview
6. Patient Journey
7. Allergic Rhinitis Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Allergic Rhinitis Unmet Needs
10. Key Endpoints of Allergic Rhinitis Treatment
11. Allergic Rhinitis Marketed Products
12. Allergic Rhinitis Emerging Therapies
13. Allergic Rhinitis: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Allergic Rhinitis
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight

If you have any query related to the report? Just speak to analyst here- https://www.delveinsight.com/report-store/allergic-rhinitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Contact Us:
Yash Bhardwaj
ybhardwaj@delveinsight.com
+1(919)321-6187
www.delveinsight.com

About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

This release was published on openPR.